Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink

Next Previous
Trial Profile

Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Jan 2019

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Asthma
  • Focus Adverse reactions

    • Most Recent Events

    • 04 Jan 2019 Planned End Date changed from 31 Dec 2018 to 31 Jan 2019.
    • 04 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Jan 2019.
    • 04 Jan 2019 Planned initiation date changed from 17 Dec 2018 to 25 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top